These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29753882)

  • 1. Circulating tumor microemboli: Progress in molecular understanding and enrichment technologies.
    Umer M; Vaidyanathan R; Nguyen NT; Shiddiky MJA
    Biotechnol Adv; 2018; 36(4):1367-1389. PubMed ID: 29753882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
    Hou JM; Krebs MG; Lancashire L; Sloane R; Backen A; Swain RK; Priest LJ; Greystoke A; Zhou C; Morris K; Ward T; Blackhall FH; Dive C
    J Clin Oncol; 2012 Feb; 30(5):525-32. PubMed ID: 22253462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modalities to enumerate circulating tumor cells in the bloodstream for cancer prognosis and to monitor the response to the therapy.
    Romano G
    Drugs Today (Barc); 2017 Sep; 53(9):501-514. PubMed ID: 29238763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of circulating tumor cells and evaluation of epithelial-mesenchymal transition patterns of circulating tumor cells in ovarian cancer.
    Jie XX; Zhang M; Du M; Cai QQ; Cong Q; Xu CJ; Zhang XY
    Transl Cancer Res; 2022 Aug; 11(8):2636-2646. PubMed ID: 36093536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cells as a window on metastasis biology in lung cancer.
    Hou JM; Krebs M; Ward T; Sloane R; Priest L; Hughes A; Clack G; Ranson M; Blackhall F; Dive C
    Am J Pathol; 2011 Mar; 178(3):989-96. PubMed ID: 21356352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating tumor cells (CTC) detection: clinical impact and future directions.
    Paterlini-Brechot P; Benali NL
    Cancer Lett; 2007 Aug; 253(2):180-204. PubMed ID: 17314005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Labyrinth Microfluidic Device Detects Circulating Tumor Cells Expressing Cancer Stem Cell Marker and Circulating Tumor Microemboli in Hepatocellular Carcinoma.
    Wan S; Kim TH; Smith KJ; Delaney R; Park GS; Guo H; Lin E; Plegue T; Kuo N; Steffes J; Leu C; Simeone DM; Razimulava N; Parikh ND; Nagrath S; Welling TH
    Sci Rep; 2019 Dec; 9(1):18575. PubMed ID: 31819089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the hormone receptor status of circulating tumor cell subpopulations based on epithelial-mesenchymal transition: a proof-of-principle study on the heterogeneity of circulating tumor cells.
    Guan X; Ma F; Liu S; Wu S; Xiao R; Yuan L; Sun X; Yi Z; Yang H; Xu B
    Oncotarget; 2016 Oct; 7(40):65993-66002. PubMed ID: 27602758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Profiling heterogenous sizes of circulating tumor microemboli to track therapeutic resistance and prognosis in advanced gastric cancer.
    Chen Y; Yuan J; Li Y; Li X; Yang Y; Li J; Li Y; Shen L
    Hum Cell; 2021 Sep; 34(5):1446-1454. PubMed ID: 34152566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
    Krebs MG; Hou JM; Sloane R; Lancashire L; Priest L; Nonaka D; Ward TH; Backen A; Clack G; Hughes A; Ranson M; Blackhall FH; Dive C
    J Thorac Oncol; 2012 Feb; 7(2):306-15. PubMed ID: 22173704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Circulating Tumor Cells and Circulating Tumor Microemboli in Gastric Cancer.
    Zheng X; Fan L; Zhou P; Ma H; Huang S; Yu D; Zhao L; Yang S; Liu J; Huang A; Cai C; Dai X; Zhang T
    Transl Oncol; 2017 Jun; 10(3):431-441. PubMed ID: 28448959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating tumor microemboli (CTM) and vimentin+ circulating tumor cells (CTCs) detected by a size-based platform predict worse prognosis in advanced colorectal cancer patients during chemotherapy.
    Zhang D; Zhao L; Zhou P; Ma H; Huang F; Jin M; Dai X; Zheng X; Huang S; Zhang T
    Cancer Cell Int; 2017; 17():6. PubMed ID: 28070168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial-to-mesenchymal transition leads to disease-stage differences in circulating tumor cell detection and metastasis in pre-clinical models of prostate cancer.
    Lowes LE; Goodale D; Xia Y; Postenka C; Piaseczny MM; Paczkowski F; Allan AL
    Oncotarget; 2016 Nov; 7(46):76125-76139. PubMed ID: 27764810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights on CTC Biology and Clinical Impact Emerging from Advances in Capture Technology.
    Bailey PC; Martin SS
    Cells; 2019 Jun; 8(6):. PubMed ID: 31174404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesenchymal Characteristics and Predictive Biomarkers on Circulating Tumor Cells for Therapeutic Strategy.
    Okabe T; Togo S; Fujimoto Y; Watanabe J; Sumiyoshi I; Orimo A; Takahashi K
    Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33266262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced detection and comprehensive in situ phenotypic characterization of circulating and disseminated heteroploid epithelial and glioma tumor cells.
    Ge F; Zhang H; Wang DD; Li L; Lin PP
    Oncotarget; 2015 Sep; 6(29):27049-64. PubMed ID: 26267323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future role of circulating tumor cells in patients with epithelial ovarian cancer.
    Van Berckelaer C; Brouwers AJ; Peeters DJ; Tjalma W; Trinh XB; van Dam PA
    Eur J Surg Oncol; 2016 Dec; 42(12):1772-1779. PubMed ID: 27265041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitive and Specific Biomimetic Lipid Coated Microfluidics to Isolate Viable Circulating Tumor Cells and Microemboli for Cancer Detection.
    Chen JY; Tsai WS; Shao HJ; Wu JC; Lai JM; Lu SH; Hung TF; Yang CT; Wu LC; Chen JS; Lee WH; Chang YC
    PLoS One; 2016; 11(3):e0149633. PubMed ID: 26938471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted downregulation of HIF-1α for restraining circulating tumor microemboli mediated metastasis.
    Du J; Wang C; Chen Y; Zhong L; Liu X; Xue L; Zhang Y; Li Y; Li X; Tang C; Su Z; Zhang C
    J Control Release; 2022 Mar; 343():457-468. PubMed ID: 35124127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.